Women's health refers to the overall well-being experienced by women - this includes physical, mental, and social well-being. It deals with the diagnosis and treatment of various diseases and conditions that affect women such as HIV/AIDS, endometriosis, infertility, polycystic ovary syndrome, postmenopausal osteoporosis, and cancer (primarily ovarian and breast cancer).
The limited funding for public health clinics globally has led to a rise in common STIs such as chlamydia, syphilis, and gonorrhea. Such diseases should be treated urgently as they can cause pelvic inflammatory diseases, stillbirths, neonatal infections, and infertility. Various public health institutes highly recommend that women who are sexually active must undergo STI screening once a year. The increase in detections of STIs will positively affect this market.
According to the report, the rise in the number of older women worldwide has spurred the market, with companies investing in R&D to develop new women's health solutions to enhance their existing portfolio. Many of the diseases women are diagnosed with are associated with old age. This will fuel the growth of the women's health market over the forecast period.
Further, the report states that one of the major issues faced by women is the cost of treatment and the inaccessibility of therapies to treat diseases, especially in developing and under-developing countries.
Key questions answered in this report:
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?